{
    "eid": "2-s2.0-85064654196",
    "title": "Efficacy of azithromycin 1.5% eyedrops vs oral doxycycline in meibomian gland dysfunction: a randomized trial",
    "cover-date": "2019-06-04",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Ophthalmology",
            "@code": "2731",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Sensory Systems",
            "@code": "2809",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Cellular and Molecular Neuroscience",
            "@code": "2804",
            "@abbrev": "NEUR"
        }
    ],
    "keywords": [
        "Azithromycin",
        "Doxycycline",
        "Meibomian gland dysfunction",
        "Meibum quality",
        "Ocular surface disease"
    ],
    "authors": [
        "Vannarut Satitpitakul",
        "Kitiya Ratanawongphaibul",
        "Ngamjit Kasetsuwan",
        "Usanee Reinprayoon"
    ],
    "citedby-count": 17,
    "ref-count": 19,
    "ref-list": [
        "The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD",
        "Benefits of omega-3 fatty acid dietary supplementation on health-related quality of life in patients with meibomian gland dysfunction",
        "The international workshop on meibomian gland dysfunction: executive summary",
        "Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study",
        "Oral azithromycin versus doxycycline in meibomian gland dysfunction: a randomised double-masked open-label clinical trial",
        "Current evidence for topical azithromycin 1% ophthalmic solution in the treatment of blepharitis and blepharitis-associated ocular dryness",
        "Efficacy of azithromycin 1% ophthalmic solution for treatment of ocular surface disease from posterior blepharitis",
        "Entry of four tetracyclines into saliva and tears",
        "Current and emerging therapeutic strategies for the treatment of meibomian gland dysfunction (MGD)",
        "Ocular surface distribution and pharmacokinetics of a novel ophthalmic 1% azithromycin formulation",
        "Topical azithromycin therapy for meibomian gland dysfunction: clinical response and lipid alterations",
        "Methodologies to diagnose and monitor dry eye disease: Report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop",
        "Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis",
        "Topical azithromycin as a novel treatment for ocular rosacea",
        "The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction",
        "The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland",
        "The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction",
        "Effects of azithromycin on gene expression profiles of proinflammatory and anti-inflammatory mediators in the eyelid margin and conjunctiva of patients with meibomian gland disease",
        "Can tetracycline antibiotics duplicate the ability of azithromycin to stimulate human meibomian gland epithelial cell differentiation?"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60022183",
        "affilname": "King Chulalongkorn Memorial Hospital",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Chulalongkorn University"
    ]
}